Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose

K-Number: K192913 · 2021-01-19

ApplicantImicryl Dis Malzemeleri Sanayi VE Ticaret AS
Decision Date2021-01-19
Product CodeKLE
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose is the device name listed in this FDA 510(k) record. The listed applicant is Imicryl Dis Malzemeleri Sanayi VE Ticaret AS. It received FDA 510(k) clearance on 2021-01-19 under 510(k) number K192913. The device is classified under product code KLE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose?

R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose is a medical device that received FDA 510(k) clearance on 2021-01-19. The listed applicant is Imicryl Dis Malzemeleri Sanayi VE Ticaret AS. The 510(k) number is K192913.

When did R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose receive FDA 510(k) clearance?

R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose received FDA 510(k) clearance on 2021-01-19, under 510(k) number K192913.

Who is the listed applicant for R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose?

The FDA 510(k) record lists Imicryl Dis Malzemeleri Sanayi VE Ticaret AS as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose?

The FDA product code for R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose is KLE.

Other records listing Imicryl Dis Malzemeleri Sanayi VE Ticaret AS as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K220077IMICRYL Composite, Composite Flow MaterialsK213609NOVA RESIN dual cure, self adhesive resin cementK210473Nova Glass Cements (Nova Glass L, Nova Glass F, Nova Glass LC, Nova Glass BF, Nova Glass L Plus)K192178R&D Series Nova Compo N

Related Devices (Code: KLE)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260485Any-EtchMediclus Co., Ltd.K260430Porcelain Etch GelBelport Company, Inc., Gingi-PakK252450Adhese 2Ivoclar Vivadent, Inc.K260682Bond-PR™ Universal AdhesivePremier Dental Products CompanyK251587VITA VMLC PrimerVita Zahnfabrik H. Rauter GmbH & Co. Kg.K252151els unibondSaremco Dental AG

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑